Negative regulation of myeloid-derived suppressor cells in cancer

Immunological Investigations

Volumn 41, Issue 6-7, 2012, Pages 562-580

  Qu, Peng ^a   Boelte, Kimberly C ^a   Lin, P Charles ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer; Inflammation; MDSC

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; MACROPHAGE ELASTASE; MICRORNA 146A; MICRORNA 155; MICRORNA 223; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STAT3 PROTEIN; VASCULOTROPIN;

ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CARCINOGENESIS; CELL LINEAGE; CELL MIGRATION; CLONAL ANERGY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; IMMUNE RESPONSE; IMMUNOTHERAPY; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; METASTASIS; MYELOID DERIVED SUPPRESSOR CELL; NATURAL KILLER CELL; NITRATION; NITROSYLATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SUPPRESSOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; TUMOR VOLUME; UPREGULATION;

ANIMALS; ANTIGENS, CD; CELL COMMUNICATION; CELL PROLIFERATION; DENDRITIC CELLS; HUMANS; INFLAMMATION; MICE; MYELOID PROGENITOR CELLS; NEOPLASM PROTEINS; NEOPLASMS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TUMOR ESCAPE;

EID: 84866905860     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2012.685538     Document Type: Article

References (107)

1. Adeegbe, D., Serafini, P., Bronte, V., Zoso, A., Ricordi, C., Inverardi, L. (2011). In vivoinduction of myeloid suppressor cells and CD4( +)Foxp3( +) T regulatory cells prolongsskin allograft survival in mice. Cell Transplant. 20: 941-954.
2. Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C.,Carbone, D. P., Gabrilovich, D. I. (2001). Increased production of immature myeloidcells in cancer patients: a mechanism of immunosuppression in cancer. J. Immunol.166: 678-689.
3. Boelte, K. C., Gordy, L. E., Joyce, S., Thompson, M. A., Yang, L., Lin, P. C. (2011). Rgs2mediates pro-angiogenic function of myeloid derived suppressor cells in the tumormicroenvironment via upregulation of MCP-1. PloS One 6: e18534.
4. Bogdan, C. (2011). Regulation of lymphocytes by nitric oxide. Meth. Mol. Biol.677: 375-393.
5. Boutte, A. M., McDonald, W. H., Shyr, Y., Yang, L., Lin, P. C. (2011). Characterization ofthe MDSC proteome associated with metastatic murine mammary tumors usinglabel-free mass spectrometry and shotgun proteomics. PloS One 6: e22446.
6. Bronstein-Sitton, N., Cohen-Daniel, L., Vaknin, I., Ezernitchi, A. V., Leshem, B., Halabi,A., Houri-Hadad, Y., Greenbaum, E., Zakay-Rones, Z., Shapira, L., Baniyash, M.(2003). Sustained exposure to bacterial antigen induces interferon-gammadependentT cell receptor zeta down-regulation and impaired T cell function. Nat.Immunol. 4: 957-964.
7. Bronte, V. (2009). Myeloid-derived suppressor cells in inflammation: Uncovering cellsubsets with enhanced immunosuppressive functions. Eur. J. Immunol.39: 2670-2672.
8. Bronte, V., Apolloni, E., Cabrelle, A., Ronca, R., Serafini, P., Zamboni, P., Restifo, N. P.,Zanovello, P. (2000). Identification of a CD11b( +)/Gr-1( +)/CD31( +) myeloidprogenitor capable of activating or suppressing CD8( +) T cells. Blood 96: 3838-3846.
9. Bronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., Restifo, N. P.(1999). Unopposed production of granulocyte-macrophage colony-stimulating factorby tumors inhibits CD8 + T cell responses by dysregulating antigen-presenting cellmaturation. J. Immunol. 162: 5728-5737.
10. Bronte, V., Serafini, P., De Santo, C., Marigo, I., Tosello, V., Mazzoni, A., Segal, D. M.,Staib, C., Lowel, M., Sutter, G., et al. (2003a). IL-4-induced arginase 1 suppressesalloreactive T cells in tumor-bearing mice. J. Immunol. 170: 270-278.
11. Bronte, V., Serafini, P., Mazzoni, A., Segal, D. M., Zanovello, P. (2003b). L-argininemetabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol.24: 302-306.
12. Bronte, V., Wang, M., Overwijk, W. W., Surman, D. R., Pericle, F., Rosenberg, S. A.,Restifo, N. P. (1998). Apoptotic death of CD8 + T lymphocytes after immunization: induction of a suppressive population of Mac-1 +Gr-1 + cells. J. Immunol.161: 5313-5320.
13. Bunt, S. K., Clements, V. K., Hanson, E. M., Sinha, P., and Ostrand-Rosenberg, S. (2009).Inflammation enhances myeloid-derived suppressor cell cross-talk by signalingthrough Toll-like receptor 4. J. Leukocyte Biol. 85: 996-1004.
14. Bunt, S. K., Sinha, P., Clements, V. K., Leips, J., Ostrand-Rosenberg, S. (2006).Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression.J. Immunol. 176: 284-290.
15. Bunt, S. K., Yang, L., Sinha, P., Clements, V. K., Leips, J., Ostrand-Rosenberg, S. (2007).Reduced inflammation in the tumor microenvironment delays the accumulation ofmyeloid-derived suppressor cells and limits tumor progression. Cancer Res. 67: 10019-10026.
16. Chaudhuri, A. A., So, A. Y., Sinha, N., Gibson, W. S., Taganov, K. D., O'Connell, R. M.,Baltimore, D. (2011). MicroRNA-125b potentiates macrophage activation.J. Immunol. 187: 5062-5068.
17. Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J. I., Cheng, P., Cho, H. I., Celis,E., Quiceno, D. G., Padhya, T., et al. (2010). HIF-1alpha regulates function anddifferentiation of myeloid-derived suppressor cells in the tumor microenvironment.J. Exper. Med. 207: 2439-2453.
18. Corzo, C. A., Cotter, M. J., Cheng, P., Cheng, F., Kusmartsev, S., Sotomayor, E., Padhya,T., McCaffrey, T. V., McCaffrey, J. C., Gabrilovich, D. I. (2009). Mechanism regulatingreactive oxygen species in tumor-induced myeloid-derived suppressor cells.J. Immunol.182, 5693-5701.
19. De Santo, C., Serafini, P., Marigo, I., Dolcetti, L., Bolla, M., Del Soldato, P., Melani, C.,Guiducci, C., Colombo, M. P., Iezzi, M., et al. (2005). Nitroaspirin corrects immunedysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination.Proc. Nat'l. Acad. Sci. USA 104: 4185-4190.
20. De Wilde, V., Van Rompaey, N., Hill, M., Lebrun, J. F., Lemaitre, P., Lhomme, F., Kubjak,C., Vokaer, B., Oldenhove, G., Charbonnier, L. M., et al. (2009). Endotoxin-inducedmyeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am. J. Transplant. 9: 2034-2047.
21. Delano, M. J., Scumpia, P. O., Weinstein, J. S., Coco, D., Nagaraj, S., Kelly-Scumpia,K. M., O'Malley, K. A., Wynn, J. L., Antonenko, S., Al-Quran, S. Z., et al. (2007).MyD88-dependent expansion of an immature GR-1( +)CD11b( +) population inducesT cell suppression and Th2 polarization in sepsis. J. Exper. Med. 204: 1463-1474.
22. Ezernitchi, A. V., Vaknin, I., Cohen-Daniel, L., Levy, O., Manaster, E., Halabi, A.,Pikarsky, E., Shapira, L., Baniyash, M. (2006). TCR zeta down-regulation underchronic inflammation is mediated by myeloid suppressor cells differentially distributedbetween various lymphatic organs. J. Immunol. 177: 4763-4772.
23. Fridlender, Z. G., Sun, J., Mishalian, I., Singhal, S., Cheng, G., Kapoor, V., Horng, W.,Fridlender, G., Bayuh, R., Worthen, G. S., Albelda, S. M. (2012). Transcriptomicanalysis comparing tumor-associated neutrophils with granulocytic myeloid-derivedsuppressor cells and normal neutrophils. PloS One 7: e31524.
24. Fu, H., Hu, Z., Wen, J., Wang, K., Liu, Y. (2009). TGF-beta promotes invasion andmetastasis of gastric cancer cells by increasing fascin1 expression via ERK andJNK signal pathways. Acta Biochim. Biophys. Sinica 41: 648-656.
25. Fujita, M., Kohanbash, G., Fellows-Mayle, W., Hamilton, R. L., Komohara, Y., Decker,S. A., Ohlfest, J. R., Okada, H. (2011). COX-2 blockade suppresses gliomagenesis byinhibiting myeloid-derived suppressor cells. Cancer Res. 71: 2664-2674.
26. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., Carbone, D. P.(1998). Vascular endothelial growth factor inhibits the development of dendritic cellsand dramatically affects the differentiation of multiple hematopoietic lineagesin vivo. Blood 92: 4150-4166.
27. Gabrilovich, D. I., Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators ofthe immune system. Nature Rev. Immunol. 9: 162-174.
28. Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., Kast, W. M. (2001). Mechanism ofimmune dysfunction in cancer mediated by immature Gr-1 + myeloid cells.J. Immunol. 166: 5398-5406.
29. Garcia, M. R., Ledgerwood, L., Yang, Y., Xu, J., Lal, G., Burrell, B., Ma, G., Hashimoto, D.,Li, Y., Boros, P., et al. (2010). Monocytic suppressive cells mediate cardiovasculartransplantation tolerance in mice. J. Clin. Investig. 120: 2486-2496.
30. Greten, T. F., Manns, M. P., Korangy, F. (2011). Myeloid derived suppressor cells inhuman diseases. Inter. Immunopharmacol. 11: 802-807.
31. Haile, L. A., Gamrekelashvili, J., Manns, M. P., Korangy, F., Greten, T. F. (2010). CD49dis a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.J. Immunol. 185: 203-210.
32. Hanson, E. M., Clements, V. K., Sinha, P., Ilkovitch, D., Ostrand-Rosenberg, S. (2009).Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4 + andCD8 + T cells. J. Immunol. 183: 937-944.
33. Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M. P., Greten,T. F., Korangy, F. (2008). A new population of myeloid-derived suppressor cells inhepatocellular carcinoma patients induces CD4( +)CD25( +)Foxp3( +) T cells.Gastroenterology 135: 234-243.
34. Huang, B., Pan, P. Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., Chen,S. H. (2006). Gr-1 +CD115 + immature myeloid suppressor cells mediate the developmentof tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host.Cancer Res. 66: 1123-1131.
35. Huang, Y., Chen, X., Dikov, M. M., Novitskiy, S. V., Mosse, C. A., Yang, L., Carbone, D. P.(2007). Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesisassociated with elevated levels of VEGF. Blood 110: 624-631.
36. Johnnidis, J. B., Harris, M. H., Wheeler, R. T., Stehling-Sun, S., Lam, M. H., Kirak, O.,Brummelkamp, T. R., Fleming, M. D., Camargo, F. D. (2008). Regulation of progenitorcell proliferation and granulocyte function by microRNA-223. Nature 451: 1125-1129.
37. Kamiyama, M., Pozzi, A., Yang, L., DeBusk, L. M., Breyer, R. M., and Lin, P. C. (2006).EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects onendothelial cell motility and survival. Oncogene 25: 7019-7028.
38. Kerr, E. C., Raveney, B. J., Copland, D. A., Dick, A. D., Nicholson, L. B. (2008). Analysis ofretinal cellular infiltrate in experimental autoimmune uveoretinitis reveals multipleregulatory cell populations. J. Autoimmun. 31: 354-361.
39. Ko, H. J., Kim, Y. J., Kim, Y. S., Chang, W. S., Ko, S. Y., Chang, S. Y., Sakaguchi, S., Kang,C. Y. (2007). A combination of chemoimmunotherapies can efficiently break selftoleranceand induce antitumor immunity in a tolerogenic murine tumor model.Cancer Res. 67: 7477-7486.
40. Kujawski, M., Kortylewski, M., Lee, H., Herrmann, A., Kay, H., and Yu, H. (2008). Stat3mediates myeloid cell-dependent tumor angiogenesis in mice. J. Clin. Investig.118: 3367-3377.
41. Kujawski, M., Zhang, C., Herrmann, A., Reckamp, K., Scuto, A., Jensen, M., Deng,J., Forman, S., Figlin, R., Yu, H. (2010). Targeting STAT3 in adoptively transferredT cells promotes their in vivo expansion and antitumor effects. CancerRes. 70: 9599-9610.
42. Kusmartsev, S., Cheng, F., Yu, B., Nefedova, Y., Sotomayor, E., Lush, R., Gabrilovich, D.(2003). All-trans-retinoic acid eliminates immature myeloid cells from tumorbearingmice and improves the effect of vaccination. Cancer Res. 63: 4441-4449.
43. Kusmartsev, S., Gabrilovich, D. I. (2005). STAT1 signaling regulates tumor-associatedmacrophage-mediated T cell deletion. J. Immunol. 174: 4880-4891.
44. Kusmartsev, S., Nagaraj, S., Gabrilovich, D. I. (2005). Tumor-associated CD8 + T celltolerance induced by bone marrow-derived immature myeloid cells. J. Immunol.175: 4583-4592.
45. Kusmartsev, S., Nefedova, Y., Yoder, D., Gabrilovich, D. I. (2004). Antigen-specific inhibitionof CD8 + T cell response by immature myeloid cells in cancer is mediated byreactive oxygen species. J. Immunol. 172: 989-999.
46. Lechner, M. G., Megiel, C., Russell, S. M., Bingham, B., Arger, N., Woo, T., Epstein, A. L.(2011). Functional characterization of human Cd33 + and Cd11b + myeloid-derivedsuppressor cell subsets induced from peripheral blood mononuclear cells co-culturedwith a diverse set of human tumor cell lines. J. Trans. Med. 9: 90.
47. Lees, J. R., Azimzadeh, A. M., Bromberg, J. S. (2011). Myeloid derived suppressor cells intransplantation. Curr. Opin. Immunol. 23: 692-697.
48. Lesokhin, A. M., Hohl, T. M., Kitano, S., Cortez, C., Hirschhorn-Cymerman, D., Avogadri,F., Rizzuto, G. A., Lazarus, J. J., Pamer, E. G., Houghton, A. N., et al. (2012).Monocytic CCR2( +) myeloid-derived suppressor cells promote immune escape bylimiting activated CD8 T-cell infiltration into the tumor microenvironment. CancerRes. 72: 876-886.
49. Li, H., Han, Y., Guo, Q., Zhang, M., Cao, X. (2009). Cancer-expanded myeloid-derivedsuppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1.J. Immunol. 182: 240-249.
50. Li, Q., Pan, P. Y., Gu, P., Xu, D., Chen, S. H. (2004). Role of immature myeloid Gr-1 + cellsin the development of antitumor immunity. Cancer Res. 64: 1130-1139.
51. Liu, C., Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R., Zhang, H. G. (2007).Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity intumor-bearing host. Blood 109: 4336-4342.
52. Lu, T., Ramakrishnan, R., Altiok, S., Youn, J. I., Cheng, P., Celis, E., Pisarev, V.,Sherman, S., Sporn, M. B., Gabrilovich, D. (2011a). Tumor-infiltrating myeloidcells induce tumor cell resistance to cytotoxic T cells in mice. J. Clin. Investig.121: 4015-4029.
53. Lu, Y., Jiang, F., Zheng, X., Katakowski, M., Buller, B., To, S. S., Chopp, M. (2011b). TGFbeta1promotes motility and invasiveness of glioma cells through activation ofADAM17. Oncol. Repts. 25: 1329-1335.
54. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A. (2002). Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclearphagocytes. Trends Immunol. 23: 549-555.
55. Mazzoni, A., Bronte, V., Visintin, A., Spitzer, J. H., Apolloni, E., Serafini, P., Zanovello,P., and Segal, D. M. (2002). Myeloid suppressor lines inhibit T cell responses by anNO-dependent mechanism. J. Immunol. 168: 689-695.
56. Melani, C., Chiodoni, C., Forni, G., Colombo, M. P. (2003). Myeloid cell expansion elicitedby the progression of spontaneous mammary carcinomas in c-erbB-2 transgenicBALB/c mice suppresses immune reactivity. Blood 102: 2138-2145.
57. Min, Y., Ghose, S., Boelte, K., Li, J., Yang, L., Lin, P. C. (2011). C/EBP-delta regulatesVEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancerthrough HIF-1alpha. Oncogene 30: 4901-4909.
58. Mirza, N., Fishman, M., Fricke, I., Dunn, M., Neuger, A. M., Frost, T. J., Lush, R. M.,Antonia, S., Gabrilovich, D. I. (2006). All-trans-retinoic acid improves differentiationof myeloid cells and immune response in cancer patients. Cancer Res. 66: 9299-9307.
59. Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C.,Beschin, A., De Baetselier, P., Van Ginderachter, J. A. (2008). Identification ofdiscrete tumor-induced myeloid-derived suppressor cell subpopulations with distinctT cell-suppressive activity. Blood 111: 4233-4244.
60. Nagaraj, S., Gabrilovich, D. I. (2010). Myeloid-derived suppressor cells in human cancer.Cancer J. 16: 348-353.
61. Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L.,Schneck, J., Gabrilovich, D. I. (2007). Altered recognition of antigen is a mechanismof CD8 + T cell tolerance in cancer. Nature Med. 13: 828-835.
62. Nagaraj, S., Schrum, A. G., Cho, H. I., Celis, E., Gabrilovich, D. I. (2010). Mechanism ofT cell tolerance induced by myeloid-derived suppressor cells. J. Immunol.184: 3106-3116.
63. Nefedova, Y., Gabrilovich, D. I. (2007). Targeting of Jak/STAT pathway in antigenpresenting cells in cancer. Curr. Cancer Drug Targets 7: 71-77.
64. O'Connell, R. M., Rao, D. S., Baltimore, D. (2012). MicroRNA regulation of inflammatoryresponses. Ann. Rev. Immunol. 30: 295-312.
65. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., Boldin, M. P., Taganov, K. D., Nicoll, J.,Paquette, R. L., Baltimore, D. (2008). Sustained expression of microRNA-155 inhematopoietic stem cells causes a myeloproliferative disorder. J. Exper. Med. 205,585-594.
66. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., Baltimore, D. (2007).MicroRNA-155 is induced during the macrophage inflammatory response. Proc.Natl. Acad. Sci. USA 104: 1604-1609.
67. Ostrand-Rosenberg, S., Sinha, P. (2009). Myeloid-derived suppressor cells: linkinginflammation and cancer. J. Immunol. 182: 4499-4506.
68. Pan, P. Y., Ma, G., Weber, K. J., Ozao-Choy, J., Wang, G., Yin, B., Divino, C. M., Chen,S. H. (2010). Immune stimulatory receptor CD40 is required for T-cell suppressionand T regulatory cell activation mediated by myeloid-derived suppressor cells incancer. Cancer Res. 70: 99-108.
69. Park, Y. S., Bae, J. H., Son, C. H., Lee, K. S., Kim, W., Jung, M. H., Yang, K., Kim, S. H.,Kang, C. D. (2011). Cyclophosphamide potentiates the antitumor effect of immunizationwith injection of immature dendritic cells into irradiated tumor. Immunol.Invest. 40: 383-399.
70. Peranzoni, E., Zilio, S., Marigo, I., Dolcetti, L., Zanovello, P., Mandruzzato, S., Bronte, V.(2010). Myeloid-derived suppressor cell heterogeneity and subset definition. Curr.Opin. Immunol. 22: 238-244.
71. Prins, R. M., Scott, G. P., Merchant, R. E., Graf, M. R. (2002). Irradiated tumor cellvaccine for treatment of an established glioma. II. Expansion of myeloid suppressorcells that promote tumor progression. Cancer Immunol. Immunother. 51: 190-199.
72. Qu, P., Du, H., Li, Y., Yan, C. (2009a). Myeloid-specific expression of Api6/AIM/Sp alphainduces systemic inflammation and adenocarcinoma in the lung. J. Immunol.182: 1648-1659.
73. Qu, P., Du, H., Wang, X., Yan, C. (2009b). Matrix metalloproteinase 12 overexpression inlung epithelial cells plays a key role in emphysema to lung bronchioalveolar adenocarcinomatransition. Cancer Res. 69: 7252-7261.
74. Qu, P., Yan, C., Blum, J. S., Kapur, R., and Du, H. (2011a). Myeloid-specific expression ofhuman lysosomal acid lipase corrects malformation and malfunction of myeloidderivedsuppressor cells in lal-/-mice. J. Immunol. 187: 3854-3866.
75. Qu, P., Yan, C., Du, H. (2011b). Matrix metalloproteinase 12 overexpression in myeloidlineage cells plays a key role in modulating myelopoiesis, immune suppression, andlung tumorigenesis. Blood 117: 4476-4489.
76. Rodriguez, P. C., Ernstoff,M. S.,Hernandez, C., Atkins,M., Zabaleta, J., Sierra, R., Ochoa,A. C. (2009). Arginase I-producing myeloid-derived suppressor cells in renal cellcarcinoma are a subpopulation of activated granulocytes. Cancer Res. 69: 1553-1560.
77. Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa,J. B., Gilbert, J., Ochoa, A. C. (2005). Arginase I in myeloid suppressor cells isinduced by COX-2 in lung carcinoma. J. Exper. Med. 202: 931-939.
78. Rodriguez, P. C., Zea, A. H., Ochoa, A. C. (2003). Mechanisms of tumor evasion from theimmune response. Cancer Chemother. Biolog. Respon. Modif. 21: 351-364.
79. Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K.,Oppenheim, J. J., Murphy, W. J. (2000). Human endothelial cells express CCR2 andrespond to MCP-1: Direct role of MCP-1 in angiogenesis and tumor progression.Blood 96: 34-40.
80. Serafini, P., Borrello, I., Bronte, V. (2006a). Myeloid suppressor cells in cancer: recruitment,phenotype, properties, and mechanisms of immune suppression. Semin.Cancer Biol. 16: 53-65.
81. Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., Borrello, I. (2004a). High-dosegranulocyte-macrophage colony-stimulating factor-producing vaccines impair theimmune response through the recruitment of myeloid suppressor cells. Cancer Res.64: 6337-6343.
82. Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Zanovello, P.,Bronte, V. (2004b). Derangement of immune responses by myeloid suppressor cells.Cancer Immunol. Immunother. CII 53: 64-72.
83. Serafini, P., Meckel, K., Kelso, M., Noonan, K., Califano, J., Koch, W., Dolcetti, L., Bronte,V., Borrello, I. (2006b). Phosphodiesterase-5 inhibition augments endogenous antitumorimmunity by reducing myeloid-derived suppressor cell function. J. Exp. Med.203: 2691-2702.
84. Serafini, P., Mgebroff, S., Noonan, K., and Borrello, I. (2008). Myeloid-derived suppressorcells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells.Cancer Res. 68: 5439-5449.
85. Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber,H. P., and Ferrara, N. (2007). Tumor refractoriness to anti-VEGF treatment ismediated by CD11b +Gr1 + myeloid cells. Nat. Biotechnol. 25: 911-920.
86. Sica, A., and Bronte, V. (2007). Altered macrophage differentiation and immune dysfunctionin tumor development. J. Clin. Investig. 117: 1155-1166.
87. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., Ostrand-Rosenberg, S. (2007a).Cross-talk between myeloid-derived suppressor cells and macrophages subvertstumor immunity toward a type 2 response. J. Immunol. 179: 977-983.
88. Sinha, P., Clements, V. K., Fulton, A. M., Ostrand-Rosenberg, S. (2007b). ProstaglandinE2 promotes tumor progression by inducing myeloid-derived suppressor cells.Cancer Res. 67: 4507-4513.
89. Sinha, P., Clements, V. K., Ostrand-Rosenberg, S. (2005). Reduction of myeloid-derivedsuppressor cells and induction of M1 macrophages facilitate the rejection of establishedmetastatic disease. J. Immunol. 174: 636-645.
90. Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., and Srikrishna, G.(2008). Proinflammatory S100 proteins regulate the accumulation of myeloidderivedsuppressor cells. J. Immunol. 181: 4666-4675.
91. Solheim, J. C., Reber, A. J., Ashour, A. E., Robinson, S., Futakuchi, M., Kurz, S. G., Hood,K., Fields, R. R., Shafer, L. R., Cornell, D., et al. (2007). Spleen but not tumorinfiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3ligand injection. Cancer Gene Ther. 14: 364-371.
92. Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., Ostrand-Rosenberg, S.(2010). Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystineand cysteine. Cancer Res. 70: 68-77.
93. Suzuki, E., Kapoor, V., Jassar, A. S., Kaiser, L. R., Albelda, S. M. (2005). Gemcitabineselectively eliminates splenic Gr-1 +CD11b +myeloid suppressor cells in tumor-bearinganimals and enhances antitumor immune activity. Clin. Cancer Res. 11: 6713-6721.
94. Taganov, K. D., Boldin, M. P., Chang, K. J., Baltimore, D. (2006). NF-kappaB-dependentinduction of microRNA miR-146, an inhibitor targeted to signaling proteins of innateimmune responses. Proc. Natl. Acad. Sci. USA 103: 12481-12486.
95. Talmadge, J. E., Hood, K. C., Zobel, L. C., Shafer, L. R., Coles, M., Toth, B. (2007).Chemoprevention by cyclooxygenase-2 inhibition reduces immature myeloid suppressorcell expansion. Int. Immunopharmacol. 7: 140-151.
96. Varga, G., Ehrchen, J., Tsianakas, A., Tenbrock, K., Rattenholl, A., Seeliger, S., Mack, M.,Roth, J., Sunderkoetter, C. (2008). Glucocorticoids induce an activated, antiinflammatorymonocyte subset in mice that resembles myeloid-derived suppressorcells. J. Leukoc. Biol. 84: 644-650.
97. Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Matrisian,L. M., Carbone, D. P., Lin, P. C. (2004). Expansion of myeloid immune suppressorGr +CD11b + cells in tumor-bearing host directly promotes tumor angiogenesis.Cancer Cell 6: 409-421.
98. Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Carbone, D. P.,Matrisian, L. M., Richmond, A., Lin, P. C., Moses, H. L. (2008). Abrogation of TGFbeta signaling in mammary carcinomas recruits Gr-1 +CD11b + myeloid cells thatpromote metastasis. Cancer Cell 13: 23-35.
99. Yang, R., Cai, Z., Zhang, Y., Yutzy, W. H. t., Roby, K. F., Roden, R. B. (2006). CD80 inimmune suppression by mouse ovarian carcinoma-associated Gr-1 +CD11b + myeloidcells. Cancer Res. 66: 6807-6815.
100. Youn, J. I., Collazo, M., Shalova, I. N., Biswas, S. K., Gabrilovich, D. I. (2012).Characterization of the nature of granulocytic myeloid-derived suppressor cells intumor-bearing mice. J. Leukocyte Biol. 91: 167-181.
101. Youn, J. I., Nagaraj, S., Collazo, M., and Gabrilovich, D. I. (2008). Subsets of myeloidderivedsuppressor cells in tumor-bearing mice. J. Immunol. 181: 5791-5802.
102. Younos, I., Donkor, M., Hoke, T., Dafferner, A., Samson, H., Westphal, S., Talmadge, J.(2011). Tumor-and organ-dependent infiltration by myeloid-derived suppressorcells. Inter. Immunopharmacol. 11: 816-826.
103. Yu, B., Kusmartsev, S., Cheng, F., Paolini, M., Nefedova, Y., Sotomayor, E., Gabrilovich,D. (2003). Effective combination of chemotherapy and dendritic cell administrationfor the treatment of advanced-stage experimental breast cancer. Clin. Cancer Res.9: 285-294.
104. Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J.,McDermott, D., Quiceno, D., Youmans, A., O'Neill, A., et al. (2005). Arginaseproducingmyeloid suppressor cells in renal cell carcinoma patients: a mechanismof tumor evasion. Cancer Res. 65: 3044-3048.
105. Zhang, M., Liu, Q., Mi, S., Liang, X., Zhang, Z., Su, X., Liu, J., Chen, Y., Wang, M., Zhang,Y., et al. (2011). Both miR-17-5p and miR-20a alleviate suppressive potential ofmyeloid-derived suppressor cells by modulating STAT3 expression. J. Immunol.186: 4716-4724.
106. Zhao, J. L., Rao, D. S., Boldin, M. P., Taganov, K. D., O'Connell, R. M., Baltimore, D.(2011). NF-kappaB dysregulation in microRNA-146a-deficient mice drives the developmentof myeloid malignancies. Proc. Natl. Acad. Sci. USA 108: 9184-9189.
107. Zhu, B., Bando, Y., Xiao, S., Yang, K., Anderson, A. C., Kuchroo, V. K., Khoury, S. J.(2007). CD11b +Ly-6C(hi) suppressive monocytes in experimental autoimmuneencephalomyelitis. J. Immunol. 179: 5228-5237.